ARCHIVES

Letrozole cuts risk of recurrent breast cancer in post-menopausal women.

This article is from The Cancer Letter archive.

Vol. 29 No. 38 | October 17, 2003

Download PDF Visit The Full Archive

Related Articles

DCT Board Oks Recompetition Of Master Agreement For BRM Trials

February 4, 1983

In Brief: IU Cancer Center To Receive $15 Million for Breast Cancer

January 31, 2014

Clearinghouse Subgroup Okeys Carcinogenesis Testing for Anticancer Drugs

September 8, 1978

SSO Workshop Calls For Certification of Surgical Oncologists, Increased Commitments By NCI, ACS

November 18, 1983

For Research Projects In Cancer Therapy

March 1, 1996

US Preventive Services Task Force To Downgrade PSA Screening From “I” to “D” — As In “Don’t Do it.”

October 6, 2011